Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic

OBJECTIVE: No data are available to develop uniform recommendations for reperfusion therapies in ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to fill the evidence gap regarding STEMI reperfusion strategy during the COVID-19 era....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nan, Zhang, Min, Su, Huajun, Huang, Zhonglue, Lin, Yongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645389/
https://www.ncbi.nlm.nih.gov/pubmed/33108941
http://dx.doi.org/10.1177/0300060520966151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645389/
https://www.ncbi.nlm.nih.gov/pubmed/33108941
http://dx.doi.org/10.1177/0300060520966151

Ejemplares similares